Related Experiment Videos
Foundations of molecular therapies in breast carcinoma
1Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee 37232-6838, USA. carlos.arteaga@mcmail.vanderbilt.edu
Journal of Mammary Gland Biology and Neoplasia
|March 8, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Acquired gene alterations in patients treated with ribociclib plus endocrine therapy or endocrine therapy alone using baseline and end-of-treatment circulating tumor DNA samples in the MONALEESA-2, -3, and -7 trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2024
Pooled ctDNA analysis of MONALEESA phase III advanced breast cancer trials.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Neratinib + fulvestrant + trastuzumab for HR-positive, HER2-negative, HER2-mutant metastatic breast cancer: outcomes and biomarker analysis from the SUMMIT trial.
Annals of oncology : official journal of the European Society for Medical Oncology·2023
Crizotinib in patients with tumors harboring ALK or ROS1 rearrangements in the NCI-MATCH trial.
NPJ precision oncology·2022
Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH trial (EAY131) subprotocol Q.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breast cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Differential effects of oral contraceptives on lymph node metastasis in breast cancer: role of tumor size as an effect modifier.
Journal of mammary gland biology and neoplasia·2026
COX-2- and IDO-associated immunomodulatory functions of stage II carcinoma-associated fibroblasts in breast cancer.
Journal of mammary gland biology and neoplasia·2026
Preserving RNA quality when freezing of human milk samples must occur before extraction: Validation of methods utilized in a multi-center cohort study.
Journal of mammary gland biology and neoplasia·2026
In Vitro Model of Milking Pulses and Stretching Cycles: Assessing Mechanical Effects on Bovine Mammary Cells.
Journal of mammary gland biology and neoplasia·2026
Looking in the Rear-View Mirror: How Lineage Tracing Experiments Redefined Cell Hierarchy in the Mammary Gland.
Journal of mammary gland biology and neoplasia·2026
Exploring the Molecular and Genomic Landscape of the Dark Agouti Rat Mammary Adenocarcinoma: Preliminary Insights for Triple-Negative Breast Cancer Modeling.
Journal of mammary gland biology and neoplasia·2026
Receptor Co‑targeting Strategies for Personalized Ovarian Cancer Therapy.
International journal of nanomedicine·2026
A germline KDM3C polymorphism impairs DNA repair and sensitizes to chemoradiotherapy.
medRxiv : the preprint server for health sciences·2026
Protective Effect of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) on Liver Function: Results From MELD Analysis in Surgical Revascularization-A Preliminary Study.
Medical science monitor : international medical journal of experimental and clinical research·2026